SVB Leerink Downgrades Gemini Therapeutics Inc. (GMTX) to Market Perform

March 3, 2022 6:51 AM EST Send to a Friend
SVB Leerink analyst Marc Goodman downgraded Gemini Therapeutics Inc. (NASDAQ: GMTX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login